BA
CVRS

BKS Advisors’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

BKS Advisors’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-100,000
Closed -$83K – 248
2018
Q2 		$83K Buy
+100,000
New +$96.5K 0.03% 228
2017
Q2 		– Sell
-100,000
Closed -$131K – 215
2017
Q1 		$131K Buy
+100,000
New +$81.4K 0.06% 190

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

BKS Advisors's CVRS Position: Q3 2018 in Review

BKS Advisors sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q3 2018, closing a stake of 100,000 shares — an estimated $83K sold.

BKS Advisors first reported a position in CVRS in Q1 2017 and held it in 2 quarters. The position peaked at $131K in Q1 2017. 48 funds tracked by Wall St. Rank hold CVRS as of Q3 2018.

  • BKS Advisors reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q3 2018 after selling out during the quarter.
  • BKS Advisors sold 100,000 CORINDUS VASCULAR ROBOTICS, INC shares in Q3 2018, an estimated $83K.
  • BKS Advisors first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q1 2017 and held it in 2 quarters.
  • BKS Advisors's CORINDUS VASCULAR ROBOTICS, INC position peaked at $131K in Q1 2017.
  • 48 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q3 2018.

Based on BKS Advisors's 13F filing for Q3 2018, filed 26 Oct 2018.